A detailed history of Nuveen Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,680,413 shares of AMGN stock, worth $1.05 Billion. This represents 0.34% of its overall portfolio holdings.

Number of Shares
3,680,413
Previous 3,562,492 3.31%
Holding current value
$1.05 Billion
Previous $1.11 Billion 6.54%
% of portfolio
0.34%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $36.5 Million - $39.8 Million
117,921 Added 3.31%
3,680,413 $1.19 Billion
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $20.3 Million - $24.6 Million
77,115 Added 2.21%
3,562,492 $1.11 Billion
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $22.3 Million - $26.9 Million
-82,982 Reduced 2.33%
3,485,377 $991 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $133 Million - $150 Million
519,406 Added 17.04%
3,568,359 $1.03 Billion
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $22.7 Million - $28.2 Million
-103,990 Reduced 3.3%
3,048,953 $819 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $66.4 Million - $78.5 Million
-309,908 Reduced 8.95%
3,152,943 $700 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $196 Million - $239 Million
868,455 Added 33.47%
3,462,851 $837 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $35.7 Million - $45.4 Million
155,952 Added 6.4%
2,594,396 $681 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $2.16 Million - $2.44 Million
-9,643 Reduced 0.39%
2,438,444 $550 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $82.5 Million - $91.8 Million
357,441 Added 17.1%
2,448,087 $596 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $6.67 Million - $7.38 Million
30,422 Added 1.48%
2,090,646 $494 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $35.8 Million - $41 Million
-180,238 Reduced 8.04%
2,060,224 $463 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $155 Million - $181 Million
-729,339 Reduced 24.56%
2,240,462 $476 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $85.6 Million - $94.9 Million
-366,359 Reduced 10.98%
2,969,801 $724 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $97.4 Million - $113 Million
-438,848 Reduced 11.63%
3,336,160 $830 Million
Q4 2020

May 17, 2021

BUY
$216.38 - $257.67 $47 Million - $55.9 Million
217,071 Added 6.1%
3,775,008 $868 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $95.1 Million - $113 Million
-439,405 Reduced 10.99%
3,557,937 $818 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $22.5 Million - $25 Million
95,701 Added 2.45%
3,997,342 $1.02 Billion
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $32.9 Million - $40.3 Million
166,076 Added 4.45%
3,901,641 $920 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $84.8 Million - $112 Million
-465,451 Reduced 11.08%
3,735,565 $757 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $243 Million - $312 Million
-1,283,534 Reduced 23.4%
4,201,016 $1.01 Billion
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $94.3 Million - $113 Million
541,743 Added 10.96%
5,484,550 $1.06 Billion
Q2 2019

Aug 15, 2019

BUY
$166.7 - $195.41 $767 Million - $899 Million
4,598,329 Added 1334.87%
4,942,807 $911 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $4.08 Million - $4.6 Million
22,572 Added 7.01%
344,478 $65.4 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $7.72 Million - $9.01 Million
-43,251 Reduced 11.84%
321,906 $62.7 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $5.91 Million - $6.67 Million
31,912 Added 9.58%
365,157 $75.7 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $6.1 Million - $6.85 Million
-36,748 Reduced 9.93%
333,245 $924,000
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $1.89 Million - $2.2 Million
-11,135 Reduced 2.92%
369,993 $63.1 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $4.21 Million - $4.71 Million
24,953 Added 7.01%
381,128 $0
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $59.6 Million - $68 Million
356,175
356,175 $66.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.